Nutriband (NTRB)
Develops transdermal drug products centered on its AVERSA abuse-deterrent patch technology.
$6.85
After-hours close−0.10 (−1.44%)
At close$6.95(−10.55%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 2.90% | 352.3K shares | |
|---|---|---|---|
| 16 holders · as of Jun 30, 2026 | |||
| Insiders | 23.51% | 2.86M shares | |
| 2 holders · as of Sep 15, 2026 | |||
| Other | 73.59% | 8.95M shares | |
| remainder | |||
12.16M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
16 holders · 352.3K shares · 2 new positions · 4 increased · 4 reduced · 0 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 174.9K | 1.44% | 0 | Aug 13, 2026 |
| Geode Capital Management, LLC | 62.5K | 0.51% | −7.6K | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 25.1K | 0.21% | 0 | Aug 13, 2026 |
| State Street Corp | 25.0K | 0.21% | 0 | Aug 7, 2026 |
| Citadel Advisors LLC | 19.0K | 0.16% | +19.0Knew | Sep 2, 2026 |
| Northern Trust Corp | 11.6K | 0.10% | −2.4K | Aug 13, 2026 |
| Haven Private, LLC | 11.4K | 0.09% | 0 | Jul 29, 2026 |
| BlackRock, Inc. | 10.7K | 0.09% | +1.1K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Gareth Sheridan | 14.20% | 1.79M | 13D | Sep 15, 2026 |
| Serguei Melnik | 9.39% | 1.07M | 13D | Mar 13, 2025 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.